E-LIB Suche - Ergebnisse für: Matthews, David R.

1

Adjusting the Use of Glucose-Lowering Agents in the Real-Wo..:

Chan, Siew Pheng ; Lim, Lee-Ling ; Chan, Juliana C. N..
Diabetes Therapy. 14 (2023) 5 - p. 823-838 , 2023

2

Effects of sodium‐glucose co‐transporter‐2 inhibitors by ba..:

Avgerinos, Ioannis ; Karagiannis, Thomas ; Matthews, David R...
Diabetes, Obesity and Metabolism. 25 (2023) 10 - p. 3020-3029 , 2023

Link: https://doi.org/10.1111/..

3

Management of type 2 diabetes with the dual GIP/GLP-1 recep..:

Karagiannis, Thomas ; Avgerinos, Ioannis ; Liakos, Aris...
Diabetologia. 65 (2022) 8 - p. 1251-1261 , 2022

Link: https://doi.org/10.1007/..

4

Relative and Absolute Risk Reductions in Cardiovascular and..:

Neuen, Brendon L. ; Ohkuma, Toshiaki ; Neal, Bruce...
American Journal of Kidney Diseases. 77 (2021) 1 - p. 23-34.e1 , 2021

Link: https://doi.org/10.1053/..

5

Effects of canagliflozin on myocardial infarction: a post h..:

Yu, Jie ; Li, Jingwei ; Leaver, Phillip J...
Cardiovascular Research. 118 (2021) 4 - p. 1103-1114 , 2021

Link: https://doi.org/10.1093/..

6

Ultra‐rapid‐acting insulins for adults with diabetes: A sys..:

Avgerinos, Ioannis ; Papanastasiou, Georgia ; Karagiannis, Thomas...
Diabetes, Obesity and Metabolism. 23 (2021) 10 - p. 2395-2401 , 2021

Link: https://doi.org/10.1111/..

7

Reasons for hospitalizations in patients with type 2 diabet..:

Feng, Kent Y. ; Li, JingWei ; Ianus, Juliana...
Diabetes, Obesity and Metabolism. 23 (2021) 12 - p. 2707-2715 , 2021

Link: https://doi.org/10.1111/..

8

An exploration of the heterogeneity in effects of SGLT2 inh..:

Yu, Jie ; Zhou, Zien ; Mahaffey, Kenneth W....
International Journal of Cardiology. 324 (2021) - p. 165-172 , 2021

Link: https://doi.org/10.1016/..

9

GLP-1 receptor agonists and SGLT2 inhibitors for older peop..:

Karagiannis, Thomas ; Tsapas, Apostolos ; Athanasiadou, Eleni...
Diabetes Research and Clinical Practice. 174 (2021) - p. 108737 , 2021

Link: https://doi.org/10.1016/..

10

Correction to: Polygenic risk scores predict diabetes compl..:

Tremblay, Johanne ; Haloui, Mounsif ; Attaoua, Redha...
Diabetologia. 64 (2021) 10 - p. 2355-2356 , 2021

Link: https://doi.org/10.1007/..

11

Comparative efficacy of glucose‐lowering medications on bod..:

Tsapas, Apostolos ; Karagiannis, Thomas ; Kakotrichi, Panagiota...
Diabetes, Obesity and Metabolism. 23 (2021) 9 - p. 2116-2124 , 2021

Link: https://doi.org/10.1111/..

12

Sotagliflozin for patients with type 2 diabetes: A systemat..:

Avgerinos, Ioannis ; Karagiannis, Thomas ; Kakotrichi, Panagiota...
Diabetes, Obesity and Metabolism. 24 (2021) 1 - p. 106-114 , 2021

Link: https://doi.org/10.1111/..

13

Polygenic risk scores predict diabetes complications and th..:

Tremblay, Johanne ; Haloui, Mounsif ; Attaoua, Redha...
Diabetologia. 64 (2021) 9 - p. 2012-2025 , 2021

Link: https://doi.org/10.1007/..

14

Comparative efficacy and safety of glucose‐lowering drugs a..:

Avgerinos, Ioannis ; Manolopoulos, Apostolos ; Michailidis, Theodoros...
Diabetes, Obesity and Metabolism. 23 (2021) 3 - p. 822-831 , 2021

Link: https://doi.org/10.1111/..

15

Mediators of the Effects of Canagliflozin on Heart Failure ..:

Li, JingWei ; Woodward, Mark ; Perkovic, Vlado...
JACC: Heart Failure. 8 (2020) 1 - p. 57-66 , 2020

Link: https://doi.org/10.1016/..